Patel, Sandip http://orcid.org/0000-0002-8387-4840
Patel, Jyoti D.
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 30 June 2023
Accepted: 6 September 2023
First Online: 6 October 2023
Declarations
:
: Sandip Patel has served on advisory boards for Amgen, AstraZeneca, Bristol Myers Squibb, Certis, Eli Lilly, Genentech, Illumina, Jazz, Merck, Pfizer, Rakuten, and Tempus; his university receives research funding from Amgen, AstraZeneca/MedImmune, Bristol Myers Squibb, Eli Lilly, Fate Therapeutics, Gilead, Iovance, Merck, Pfizer, Roche/Genentech, and SQZ Biotechnologies. Jyoti D. Patel has served on advisory boards for AnHeart, AstraZeneca, Daiichi Sankyo, Genentech, and Takeda.
: Ethics guidelines are not applicable to this article, as this commentary is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.